You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TOCILIZUMAB

Showing 26 - 50 of 633
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)

Recruiting
  • Giant Cell Arteritis
  • Bonn, Germany
    Medical Clinic and Polyclinic III Internal medicine Oncology, He
Dec 16, 2022

Epilepsy Trial (Tocilizumab Prefilled Syringe [Actemra]. propofole, phenobarbital, midazolam)

Not yet recruiting
  • Epilepsy
  • Tocilizumab Prefilled Syringe [Actemra]. propofole, phenobarbital, midazolam
  • (no location specified)
Apr 21, 2022

TOcilizumab and Covid-19 : Risk of Severe INfection

Recruiting
  • Covid19
    • Paris, France
      Groupe Hospitalier Paris Saint-Joseph
    Jul 4, 2022

    Hemophagocytic Lymphohistiocytosis Trial in Philadelphia (tocilizumab)

    Withdrawn
    • Hemophagocytic Lymphohistiocytosis
    • tocilizumab
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Mar 11, 2022

    Coronavirus Infection, SARS (Severe Acute Respiratory Syndrome), Virus Diseases Trial in Cayenne (Tocilizumab, Dexamethasone)

    Completed
    • Coronavirus Infection
    • +7 more
    • Cayenne, French Guiana
      CH Andrée Rosemon
    Jun 7, 2022

    Myasthenia Gravis, Generalized Trial in China (Tocilizumab Injectable Product)

    Recruiting
    • Myasthenia Gravis, Generalized
    • Tocilizumab Injectable Product
    • Beijing, Beijing, China
    • +5 more
    Sep 15, 2022

    Rheumatoid Arthritis, Giant Cell Arteritis Trial in Australia, India, New Zealand (Tocilizumab Prefilled Syringe)

    Active, not recruiting
    • Rheumatoid Arthritis
    • Giant Cell Arteritis
    • Tocilizumab Prefilled Syringe
    • Brisbane, Australia
    • +3 more
    May 4, 2022

    Rheumatoid Arthritis Trial (CT-P47 AI (tocilizumab), CT-P47 PFS (tocilizumab))

    Not yet recruiting
    • Rheumatoid Arthritis
    • CT-P47 AI (tocilizumab)
    • CT-P47 PFS (tocilizumab)
    • (no location specified)
    Feb 14, 2023

    Rheumatoid Arthritis Trial in France (subcutaneous tocilizumab)

    Recruiting
    • Rheumatoid Arthritis
    • subcutaneous tocilizumab
    • Lyon, France
    • +3 more
    Jun 13, 2022

    Pancreatic Cancer Trial in Herlev (Nivolumab, Ipilimumab, Tocilizumab)

    Terminated
    • Pancreatic Cancer
    • Herlev, Denmark
      Herlev & Gentofte University Hospital, Denmark
    Mar 15, 2022

    Graves Ophthalmopathy Trial in Italy (Tocilizumab 20 Mg/mL Intravenous Solution, MethylPREDNISolone Injectable Solution)

    Recruiting
    • Graves Ophthalmopathy
    • Tocilizumab 20 Mg/mL Intravenous Solution
    • MethylPREDNISolone Injectable Solution
    • Milano, MI, Italy
    • +3 more
    Aug 3, 2022

    Donor-Derived Cell-Free DNA With Tocilizumab Treatment for

    Active, not recruiting
    • Rejection Chronic Renal
    • Kidney Transplant Rejection
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Jul 18, 2022

      Cytokine Release Syndrome, Covid-19 Trial in Sao Luis (Tocilizumab 180 MG/ML, Methylprednisolone Sodium Succinate)

      Terminated
      • Cytokine Release Syndrome
      • Covid-19
      • Tocilizumab 180 MG/ML
      • Methylprednisolone Sodium Succinate
      • Sao Luis, MA, Brazil
        Hospital Sao Domingos
      Mar 14, 2022

      COVID-19 Severe Respiratory Failure Trial in Alexandroupolis (Dexamethasone, Low molecular weight heparin, Anakinra 100Mg/0.67Ml

      Recruiting
      • COVID-19 Severe Respiratory Failure
      • Alexandroupolis, Evros, Greece
        University Hospital of Alexandroupolis
      Mar 11, 2022

      Unresectable Pancreatic Carcinoma Trial in Herlev, Oslo (Tocilizumab, Gemcitabine, nab-Paclitaxel)

      Active, not recruiting
      • Unresectable Pancreatic Carcinoma
      • Tocilizumab
      • +2 more
      • Herlev, Denmark
      • +1 more
      Mar 15, 2022

      Leukemia Trial in Houston (Alemtuzumab, Etoposide, Dexamethasone)

      Active, not recruiting
      • Leukemia
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Feb 2, 2022

      COVID-19 Trial in New York (Tocilizumab)

      Active, not recruiting
      • COVID-19
      • Tocilizumab
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 21, 2022

      Covid19 Trial in Ipatinga, Varginha, Aracaju (Tocilizumab, Heparin - Therapeutic dosage, Heparin - Prophylactic dosage)

      Completed
      • Covid19
      • Tocilizumab
      • +2 more
      • Ipatinga, Minas Gerais, Brazil
      • +2 more
      Mar 17, 2022

      COVID-19 Virus Infection, Cytokine Storm, Corticosteroid Trial (Methylprednisolone, Tocilizumab)

      Withdrawn
      • COVID-19 Virus Infection
      • +3 more
      • (no location specified)
      Nov 22, 2021

      Melanoma Trial in Los Angeles, Boston, New York (Ipilimumab, Nivolumab, Tocilizumab)

      Recruiting
      • Melanoma
      • Los Angeles, California
      • +3 more
      Mar 29, 2022

      Acute Myocardial Infarction, Cardiogenic Shock Trial in Copenhagen (Tocilizumab, Dobutamine, NaCl 0.9%)

      Recruiting
      • Acute Myocardial Infarction
      • Cardiogenic Shock
      • Tocilizumab
      • +2 more
      • Copenhagen, Denmark
        Rigshospitalet, Copenhagen University Hospital
      Apr 21, 2022

      Multiple Myeloma Trial (Teclistamab, Tocilizumab)

      Not yet recruiting
      • Multiple Myeloma
      • (no location specified)
      Jul 24, 2023

      Rheumatoid Arthritis Trial in China (Tocilizumab, MTX, Placebo Matched to MTX)

      Completed
      • Rheumatoid Arthritis
      • Tocilizumab
      • +3 more
      • Baotou, China
      • +19 more
      Dec 5, 2022

      Rapid Progressive Interstitial Lung Diseases Trial in Beijing (Tocilizumab)

      Recruiting
      • Rapid Progressive Interstitial Lung Diseases
      • Tocilizumab
      • Beijing, China
        Peking Union Medical College Hospital
      Dec 19, 2021

      Giant Cell Arteritis Trial in Basel, Bern (Tocilizumab)

      Completed
      Has Results
      • Giant Cell Arteritis
      • Tocilizumab
      • Basel, Switzerland
      • +1 more
      Nov 4, 2021